Only a handful of longitudinal studies has been conducted to analyze ANA and ENA changes over time in different autoimmune diseases,3,19,21,27–29 and further work is required to investigate in larger cohorts how autoantibodies change with disease course and if these changes reflect different underlying biological pathways. This evidence concerns the gene BTG3 and autoimmune disease.